學生對 弗吉尼亚大学 提供的 Physician/Student Opioid Use Disorder Medication Assisted Treatment Waiver Training 的評價和反饋
This online course opportunity is made possible through a joint partnership with University of Virginia School of Medicine (UVASOM) and Nursing (SON) and the American Academy of Addiction Psychiatry (AAAP), Data 2000 sponsor for this MAT waiver training. This content was created by the AAAP and has been used with permission. This course is designed to highlight important issues affecting prescribing clinicians regarding the new requirements and guidelines in opioid prescribing and management for acute and chronic pain management. The course consists of 8 individual sessions of the required 8 hours of content for physicians who wish to apply for a waiver to prescribe buprenorphine for the treatment of opioid use disorders. Sessions include a non-graded pre assessment and 8 recorded audio sessions with graded post-module questions the total of which must be completed with 80% accuracy. Some modules contain a case study component. A certification of completion will be issued for successful completion of the entire training. Students who successfully complete the course during their educational program can apply for their waiver when they obtain their full DEA license.
Estimated time to complete this activity: 9.5 hours
Release date: March 1, 2020
UVA Grant Dates: 09/30/2019 – 09/29/2022
Funding for this initiative was made possible by a grant from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government....
1 - Physician/Student Opioid Use Disorder Medication Assisted Treatment Waiver Training 的 4 個評論（共 4 個）
創建者 Xiaoyu C
Very informative and helpful!
創建者 Navin P
創建者 ماجد ا
創建者 Md S H
Very vast and also not so good, you can make it interesting by video lecture but it is not there.